Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...

Within six months, former US Army sergeant Mark Millich began experiencing dizziness, fatigue, cold sweats and was slurring his words - which he described it as feeling 'lobotomized'.

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering online consultations and direct-to-door deliveries. Their nearly ubiquitous ...